PATENT CLAIM ANALYSIS

Application Number: 15944700
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "020800"]

Abstract:
Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Claim (Index 25):
A method of treating an ocular disease characterized by angiogenesis and/or vascular permeability or leakage in a subject, comprising administering an effective amount of a pharmaceutical composition comprising a non-naturally occurring cystine knot peptide (CKP) that binds to vascular endothelial growth factor A (VEGF-A) to the subject.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15267087', '10182509', '14745562', '14384694', '14563362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7200193631687991
- 35 USC 102 Novelty (BERT): 0.5896322875007703
- Combined Prediction Score: 0.7069806556019962
- Mean Citation Score: 328.71075600000006
- Max Citation Score: 560.7332
- Similarity Product: 383.05391937472814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test